Jean-François Perrier

Has open position

Professor at University of Copenhagen

University of Copenhagen
Country flagDenmark

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Positions (1)

Publisher
source

Jean-François Perrier

University Name
.

University of Copenhagen

The Perrier Lab at the Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, is recruiting a PhD fellow to investigate gain-of-function (GOF) mutations in GABAA receptor subunits associated with developmental and epileptic encephalopathies (DEEs). DEEs are severe, early-onset disorders that may involve intractable epilepsy, intellectual disability, developmental delay or regression, movement disorders, and autism spectrum disorders. Although GABAA receptor missense variants have often been interpreted as causing loss of receptor function, recent collaborative work indicates that GOF variants are also common and that their functional effects correlate closely with patient phenotypes. The project addresses how mutations that increase inhibitory signaling can nevertheless produce epileptic and developmental disease. The fellow will study animal models carrying patient-associated GOF GABAA receptor mutations and examine their effects from whole-animal behavior to neuronal microcircuit activity. In vivo work will include monitoring animal behavior and recording electrocorticographic activity to identify abnormalities linked to clinical symptoms. In vitro experiments will use brain-slice preparations and patch-clamp recordings to measure single-neuron and microcircuit activity, with particular attention to the thalamo-cortical loop and comparisons between mutant animals and wild-type littermates. The project will also incorporate calcium imaging, optogenetic and pharmacological approaches. The fellow will design, conduct, and analyze experiments investigating how the mutations alter the electrical properties of thalamo-cortical microcircuits, and will contribute to testing targeted treatments first in vitro and subsequently in vivo. The research is conducted within the “From disease-causing variants to targeted therapy in GABA-A receptor related epilepsies” consortium, involving the University of Copenhagen, Filadelfia Hospital in Denmark, and the University of Sydney in Australia. Close collaboration with Filadelfia Hospital provides contact with a patient cohort affected by these rare and severe conditions. The fellow will join a collegial and scientifically ambitious environment with state-of-the-art laboratories, advanced core facilities, modern offices, and opportunities to develop expertise in the mechanisms of DEEs. The project is supervised by Professor Jean-François Perrier and is based at Maersk Tower, The Panum Institute, University of Copenhagen.

New Today